↓ Skip to main content

Heparin versus placebo for acute coronary syndromes

Overview of attention for article published in this source, April 2008
Altmetric Badge

Mentioned by

blogs
2 blogs
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
38 Mendeley
connotea
1 Connotea
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Heparin versus placebo for acute coronary syndromes
Published by
John Wiley & Sons, Ltd, April 2008
DOI 10.1002/14651858.cd003462.pub2
Pubmed ID
Authors

Magee, Kirk, Campbell, Samuel G, Moher, David, Rowe, Brian H

Abstract

Acute coronary syndromes (ACS) represent a spectrum of disease including unstable angina (UA) and non-ST segment myocardial infarction (NSTEMI). Despite treatment with aspirin, beta-blockers and nitroglycerin, UA/NSTEMI is still associated with significant morbidity and mortality. Although emerging evidence suggests that low molecular weight heparin (LMWH) is more efficacious compared to unfractionated heparin (UFH), there is limited data to support the role of heparins as a drug class in the treatment of ACS.

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 38 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 5%
India 1 3%
United Kingdom 1 3%
Unknown 34 89%

Demographic breakdown

Readers by professional status Count As %
Student > Postgraduate 7 18%
Researcher 6 16%
Student > Master 5 13%
Student > Doctoral Student 4 11%
Other 3 8%
Other 7 18%
Unknown 6 16%
Readers by discipline Count As %
Medicine and Dentistry 27 71%
Psychology 1 3%
Agricultural and Biological Sciences 1 3%
Social Sciences 1 3%
Neuroscience 1 3%
Other 0 0%
Unknown 7 18%